1 year return (CAGR)
-70.43%
Oncopeptides AB Exchange (ST, SEK)
ONCO.ST
1.70
-0.02 (-1.39%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-27.78%
5 year return (CAGR)
-6.88%
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
733.31M
Price/Sales
7.70
Ent value
772.78M
Price/Book
29.42
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-41.60%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.72 |
| Daily high | 1.84 |
| Daily low | 1.66 |
| Daily Volume | 6.63M |
| All-time high | 131.08 |
| 1y analyst estimate | 2.83 |
| Beta | -0.51 |
| EPS (TTM) | -0.56 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 19 Feb 2026 |
Downside potential
Loading...
Downside potential data
| ONCO.ST | S&P500 | |
| Current price drop from All-time high | -98.70% | -5.92% |
| Highest price drop | -99.12% | -56.47% |
| Date of highest drop | 23 Jan 2025 | 9 Mar 2009 |
| Avg drop from high | -64.15% | -10.64% |
| Avg time to new high | 51 days | 12 days |
| Max time to new high | 2094 days | 1805 days |
News
Oncopeptides AB (STU:OND) reports 41% year-over-year sales growth, a positive CHMP opinion for label expansion, and promising blood-brain barrier penetration data in glioblastoma.
November 5, 2026
Strong revenue growth and disciplined cost management position the company for positive cash flow in 2027, despite regional market challenges.
August 27, 2026
Oncopeptides AB (FRA:OND) reports impressive sales growth and strategic advancements, despite facing regional hurdles and regulatory delays.
May 13, 2026
Despite challenges in key markets, Oncopeptides AB (STU:OND) reports significant sales growth and outlines strategic initiatives to enhance its pipeline and market reach.
February 19, 2026
Oncopeptides AB (FRA:OND) reports a 174% increase in net sales and robust gross margins, while navigating operational and market expansion hurdles.
November 12, 2025